<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
<PubmedArticle>
    <MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM">
        <PMID Version="1">27158389</PMID>
        <DateCompleted>
            <Year>2016</Year>
            <Month>05</Month>
            <Day>09</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2018</Year>
            <Month>11</Month>
            <Day>13</Day>
        </DateRevised>
        <Article PubModel="Electronic-eCollection">
            <Journal>
                <ISSN IssnType="Print">1943-8141</ISSN>
                <JournalIssue CitedMedium="Print">
                    <Volume>8</Volume>
                    <Issue>2</Issue>
                    <PubDate>
                        <Year>2016</Year>
                    </PubDate>
                </JournalIssue>
                <Title>American journal of translational research</Title>
                <ISOAbbreviation>Am J Transl Res</ISOAbbreviation>
            </Journal>
            <ArticleTitle>miR-26a inhibits the proliferation of ovarian cancer cells via regulating CDC6 expression.</ArticleTitle>
            <Pagination>
                <MedlinePgn>1037-46</MedlinePgn>
            </Pagination>
            <Abstract>
                <AbstractText>MicroRNAs (miRNA) play important regulatory roles in the occurrence and development of cancers. This study aimed to investigate the effects of miR-26a on the proliferation and apoptosis of ovarian cancer cells and explore the potential mechanism. qRT-PCR was performed to measure the miR-26a expression in 46 ovarian cancer tissues, and results showed miR-26a expression reduced significantly when compared with normal ovarian tissues (P&lt;0.05). Moreover, miR-26a expression was related to the extent of cell differentiation and clinical stage of ovarian cancer (P&lt;0.05). miR-26a mimic was transfected into SKOV3 cells and ES2 cells, and CCK8 assay, colony formation assay and flow cytometry showed miR-26a over-expression could significantly inhibit the proliferation of ovarian cancer cells and induce their apoptosis. Bioinformatics analysis revealed Cdc6 was a target gene of miR-26a. dual-luciferase assay and validation assay showed miR-26a could act on the 3'UTR of Cdc6 to regulate Cdc6 expression. These findings suggest that miR-26a may act on the 3'UTR of Cdc6 to regulate Cdc6 expression, which then inhibit the proliferation of ovarian cancer cells and induce their apoptosis. Our findings provide a new target for the diagnosis and therapy of ovarian cancer. </AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Sun</LastName>
                    <ForeName>Ting-Yi</ForeName>
                    <Initials>TY</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Pathology, Henan Provincial People's Hospital Zhengzhou, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Xie</LastName>
                    <ForeName>Hong-Jian</ForeName>
                    <Initials>HJ</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Pathology, Henan Provincial People's Hospital Zhengzhou, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>He</LastName>
                    <ForeName>Hui</ForeName>
                    <Initials>H</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Pathology, Henan Provincial People's Hospital Zhengzhou, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Li</LastName>
                    <ForeName>Zhen</ForeName>
                    <Initials>Z</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Pathology, Henan Provincial People's Hospital Zhengzhou, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Kong</LastName>
                    <ForeName>Ling-Fei</ForeName>
                    <Initials>LF</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Pathology, Henan Provincial People's Hospital Zhengzhou, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2016</Year>
                <Month>02</Month>
                <Day>15</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>Am J Transl Res</MedlineTA>
            <NlmUniqueID>101493030</NlmUniqueID>
        </MedlineJournalInfo>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Ovarian cancer</Keyword>
            <Keyword MajorTopicYN="N">cell division cycle 6</Keyword>
            <Keyword MajorTopicYN="N">miR-26a</Keyword>
            <Keyword MajorTopicYN="N">proliferation</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2015</Year>
                <Month>12</Month>
                <Day>29</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2016</Year>
                <Month>01</Month>
                <Day>21</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2016</Year>
                <Month>5</Month>
                <Day>10</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2016</Year>
                <Month>5</Month>
                <Day>10</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2016</Year>
                <Month>5</Month>
                <Day>10</Day>
                <Hour>6</Hour>
                <Minute>1</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>epublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">27158389</ArticleId>
            <ArticleId IdType="pmc">PMC4846946</ArticleId>
        </ArticleIdList>
        <ReferenceList>
            <Reference>
                <Citation>Trends Cardiovasc Med. 2014 Aug;24(6):241-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25066487</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Mol Cancer Res. 2015 Mar;13(3):393-401</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25304686</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>PLoS One. 2013 Aug 28;8(8):e72662</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24015269</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Tumour Biol. 2014 Oct;35(10 ):9725-33</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24972966</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>BMC Cancer. 2012 Dec 28;12:627</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23272653</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Technol Cancer Res Treat. 2013 Apr;12(2):173-81</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22974333</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Int J Gynecol Cancer. 2010 Jul;20(5):856-61</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20606534</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Proc Natl Acad Sci U S A. 1997 Jan 7;94(1):142-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">8990175</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Mol Cancer Res. 2014 Nov;12(11):1535-46</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25100863</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>EMBO J. 1995 Aug 1;14(15):3788-99</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">7641697</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Methods Mol Biol. 2009;511:333-59</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19347305</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cancer Res. 2007 Sep 15;67(18):8699-707</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17875710</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Anticancer Res. 2008 Nov-Dec;28(6A):3763-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19189662</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Genome Res. 2009 Jan;19(1):92-105</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18955434</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Obstet Gynecol. 2012 Mar;55(1):75-95</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22343231</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Oncol Lett. 2013 Sep;6(3):789-794</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24137412</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Biomed Res Int. 2014;2014:249393</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25295252</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 2009 Oct 8;361(15):1437-47</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19812400</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cell. 2012 Apr 27;149(3):515-24</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22541426</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>CA Cancer J Clin. 2015 Jan-Feb;65(1):5-29</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25559415</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Transcription. 2012 May-Jun;3(3):124-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22771947</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Crit Rev Biochem Mol Biol. 2016 May-Jun;51(3):121-34</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26628006</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Oncol Lett. 2011 Nov;2(6):1019-1023</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22848262</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Int J Gynecol Cancer. 2013 May;23(4):673-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23542579</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Biol Chem. 2015 Feb 13;290(7):4130</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25681511</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Carcinogenesis. 2011 Jan;32(1):2-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20952513</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Biol Chem. 2012 Oct 12;287(42):34970-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22927443</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cell. 2009 Jan 23;136(2):215-33</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19167326</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Hum Pathol. 2015 Sep;46(9):1245-56</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26216350</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Oncol Rep. 2014 Mar;31(3):1263-70</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24452597</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cell Cycle. 2011 May 1;10(9):1374-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21519187</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>

</PubmedArticleSet>